Connect with us

Health

Drug enhances bone marrow transplant outcomes for leukaemia patients – Health Europa

Experts have identified a drug that reduces the risk of leukaemia recurring when administered in combination with a bone marrow…

Published

on

Article feature image

A team of researchers from the University of Michigan Health Rogel Cancer Center have ascertained that a treatment known as interferon can lower the risk of leukaemia recurrence in high-risk patients by 20% when given alongside a bone marrow transplant.

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending